1. Home
  2. PBHC vs CELU Comparison

PBHC vs CELU Comparison

Compare PBHC & CELU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PBHC
  • CELU
  • Stock Information
  • Founded
  • PBHC 1859
  • CELU 2016
  • Country
  • PBHC United States
  • CELU United States
  • Employees
  • PBHC N/A
  • CELU N/A
  • Industry
  • PBHC Major Banks
  • CELU Biotechnology: Pharmaceutical Preparations
  • Sector
  • PBHC Finance
  • CELU Health Care
  • Exchange
  • PBHC Nasdaq
  • CELU Nasdaq
  • Market Cap
  • PBHC 108.9M
  • CELU 50.4M
  • IPO Year
  • PBHC N/A
  • CELU N/A
  • Fundamental
  • Price
  • PBHC $15.38
  • CELU $2.10
  • Analyst Decision
  • PBHC
  • CELU
  • Analyst Count
  • PBHC 0
  • CELU 0
  • Target Price
  • PBHC N/A
  • CELU N/A
  • AVG Volume (30 Days)
  • PBHC 8.8K
  • CELU 88.2K
  • Earning Date
  • PBHC 01-30-2025
  • CELU 12-06-2024
  • Dividend Yield
  • PBHC 2.60%
  • CELU N/A
  • EPS Growth
  • PBHC N/A
  • CELU N/A
  • EPS
  • PBHC 0.25
  • CELU N/A
  • Revenue
  • PBHC $35,494,000.00
  • CELU $48,200,000.00
  • Revenue This Year
  • PBHC N/A
  • CELU N/A
  • Revenue Next Year
  • PBHC N/A
  • CELU $233.89
  • P/E Ratio
  • PBHC $62.60
  • CELU N/A
  • Revenue Growth
  • PBHC N/A
  • CELU 225.94
  • 52 Week Low
  • PBHC $11.41
  • CELU $1.30
  • 52 Week High
  • PBHC $19.86
  • CELU $7.97
  • Technical
  • Relative Strength Index (RSI)
  • PBHC 28.91
  • CELU 44.10
  • Support Level
  • PBHC $17.06
  • CELU $1.94
  • Resistance Level
  • PBHC $16.60
  • CELU $2.39
  • Average True Range (ATR)
  • PBHC 0.45
  • CELU 0.17
  • MACD
  • PBHC -0.23
  • CELU -0.00
  • Stochastic Oscillator
  • PBHC 0.45
  • CELU 34.46

About PBHC Pathfinder Bancorp Inc. (MD)

Pathfinder Bancorp Inc is a holding company for Pathfinder Bank. The Pathfinder Bank is a commercial bank engaged in attracting deposits from the general public and investing such deposits, together with other sources of funds, in loans secured by residential real estate, commercial real estate, small business loans, and consumer loans. The bank invests a portion of its assets in debt securities issued by the United States Government and its agencies and sponsored enterprises, state and municipal obligations, corporate debt securities, mutual funds, and equity securities. The principal source of income is interest on loans and investment securities.

About CELU Celularity Inc.

Celularity Inc is a clinical-stage biotechnology company developing off-the-shelf placental-derived allogeneic cell therapies including genetically modified and unmodified NK cells, engineered T cells including CAR-T cells, and mesenchymal-like adherent stromal cells, targeting indications across cancer, immunologic, infectious, and degenerative diseases. It manages its operations through an evaluation of three distinct business segments which include Cell Therapy, Degenerative Disease, and bio-banking. The company generates the majority of its revenue from bio-banking segment.

Share on Social Networks: